Literature DB >> 26826926

Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.

Jianbo Wu1, Samuel D Hunt1, Haipeng Xue2, Ying Liu3, Radbod Darabi4.   

Abstract

Directed differentiation of iPS cells toward various tissue progenitors has been the focus of recent research. Therefore, generation of tissue-specific reporter iPS cell lines provides better understanding of developmental stages in iPS cells. This technical report describes an efficient strategy for generation and validation of knock-in reporter lines in human iPS cells using the Cas9-nickase system. Here, we have generated a knock-in human iPS cell line for the early myogenic lineage specification gene of PAX7. By introduction of site-specific double-stranded breaks (DSB) in the genomic locus of PAX7 using CRISPR/Cas9 nickase pairs, a 2A-GFP reporter with selection markers has been incorporated before the stop codon of the PAX7 gene at the last exon. After positive and negative selection, single cell-derived human iPS clones have been isolated and sequenced for in-frame positioning of the reporter construct. Finally, by using a nuclease-dead Cas9 activator (dCas9-VP160) system, the promoter region of PAX7 has been targeted for transient gene induction to validate the GFP reporter activity. This was confirmed by flow cytometry analysis and immunostaining for PAX7 and GFP. This technical report provides a practical guideline for generation and validation of knock-in reporters using CRISPR/Cas9 system. Published by Elsevier B.V.

Entities:  

Keywords:  CRISPR; Cas9; Cas9 nickase; GFP reporter; Homologous recombination; Human iPS cells; Knock-in; PAX7; dCas9

Mesh:

Substances:

Year:  2016        PMID: 26826926     DOI: 10.1016/j.scr.2016.01.003

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  16 in total

Review 1.  Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva.

Authors:  Emilie Barruet; Edward C Hsiao
Journal:  Bone       Date:  2017-07-14       Impact factor: 4.398

Review 2.  Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies.

Authors:  Sridhar Selvaraj; Michael Kyba; Rita C R Perlingeiro
Journal:  Trends Mol Med       Date:  2019-09       Impact factor: 11.951

3.  A Myogenic Double-Reporter Human Pluripotent Stem Cell Line Allows Prospective Isolation of Skeletal Muscle Progenitors.

Authors:  Jianbo Wu; Nadine Matthias; Jonathan Lo; Jose L Ortiz-Vitali; Annie W Shieh; Sidney H Wang; Radbod Darabi
Journal:  Cell Rep       Date:  2018-11-13       Impact factor: 9.423

Review 4.  Modeling Psychiatric Disorder Biology with Stem Cells.

Authors:  Debamitra Das; Kyra Feuer; Marah Wahbeh; Dimitrios Avramopoulos
Journal:  Curr Psychiatry Rep       Date:  2020-04-21       Impact factor: 5.285

Review 5.  Approaches to characterize the transcriptional trajectory of human myogenesis.

Authors:  HoTae Lim; In Young Choi; Sang-Hwan Hyun; Hyesoo Kim; Gabsang Lee
Journal:  Cell Mol Life Sci       Date:  2021-02-15       Impact factor: 9.261

Review 6.  Myogenic progenitor specification from pluripotent stem cells.

Authors:  Alessandro Magli; Rita R C Perlingeiro
Journal:  Semin Cell Dev Biol       Date:  2017-12       Impact factor: 7.727

Review 7.  CRISPR-Cas orthologues and variants: optimizing the repertoire, specificity and delivery of genome engineering tools.

Authors:  Alberto Cebrian-Serrano; Benjamin Davies
Journal:  Mamm Genome       Date:  2017-06-20       Impact factor: 2.957

Review 8.  Editing the genome of hiPSC with CRISPR/Cas9: disease models.

Authors:  Andrew R Bassett
Journal:  Mamm Genome       Date:  2017-03-16       Impact factor: 2.957

Review 9.  Skeletal muscle generated from induced pluripotent stem cells - induction and application.

Authors:  Yuko Miyagoe-Suzuki; Shin'ichi Takeda
Journal:  World J Stem Cells       Date:  2017-06-26       Impact factor: 5.326

10.  Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9.

Authors:  Makan Khoshnejad; Jacob S Brenner; William Motley; Hamideh Parhiz; Colin F Greineder; Carlos H Villa; Oscar A Marcos-Contreras; Andrew Tsourkas; Vladimir R Muzykantov
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.